A novel fusion protein-based vaccine comprising a cell penetrating and immunostimulatory peptide linked to human papillomavirus (HPV) type 16 E7 antigen generates potent immunologic and anti-tumor responses in mice

Autor: Granadillo, Milaid, Vallespi, Maribel G., Batte, Aileen, Mendoza, Osmany, Soria, Yordanka, Lugo, Victoria M., Torrens, Isis
Zdroj: In Vaccine 29 January 2011 29(5):920-930
Databáze: ScienceDirect